Company Filing History:
Years Active: 2017
Title: Weimei Xing: Innovator in Reverse Transcriptase Technology
Introduction
Weimei Xing is a notable inventor based in Palo Alto, CA, recognized for his contributions to the field of molecular biology. His work primarily focuses on the development of mutant reverse transcriptase, which has significant implications for various biotechnological applications.
Latest Patents
Weimei Xing holds a patent for a "Mutant reverse transcriptase and methods of use." This invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The patent also discloses methods for utilizing these stable mutants, showcasing his innovative approach to enhancing reverse transcriptase functionality.
Career Highlights
Throughout his career, Weimei Xing has worked with prominent companies in the biotechnology sector. He has been associated with Agilent Technologies, Inc. and Stratagene California, where he has contributed to various research and development projects. His expertise in reverse transcriptase technology has made him a valuable asset in these organizations.
Collaborations
Weimei Xing has collaborated with several professionals in his field, including Holly Hogrefe and Bahram Arezi. These collaborations have further enriched his research and development efforts, leading to advancements in molecular biology.
Conclusion
Weimei Xing's innovative work in reverse transcriptase technology exemplifies the impact of dedicated inventors in the biotechnology industry. His contributions continue to influence research and applications in molecular biology.